FGD5P1: A Drug Target / Disease Biomarker (G100132526)

Target Name: FGD5P1

NCBI ID: G100132526

FGD5P1

Other Name(s): FYVE, RhoGEF and PH domain containing 5 pseudogene 1

FGD5P1: A Drug Target / Disease Biomarker

FGD5P1, also known as FGD5P1-T, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is FGD5P1, which stands for FGD5-related protein 1.

FGD5P1 is a member of the FGD gene family, which is known for producing proteins that are involved in the regulation of cell growth, differentiation, and survival. The FGD gene family has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

FGD5P1 is a 21-kDa protein that is expressed in the brain, heart, and kidneys. It is characterized by a N-terminus that contains a unique structural domain called N-184. This domain is known to be involved in the regulation of the activity of various enzymes, including the protein kinase BKAT3A.

FGD5P1 has been shown to be involved in the regulation of cellular processes that are important for brain development and function. For example, studies have shown that FGD5P1 is involved in the regulation of the growth and differentiation of neurons, and that it plays a role in the development of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

In addition to its role in neural development and function, FGD5P1 has also been shown to be involved in the regulation of other cellular processes that are important for overall health and wellbeing. For example, studies have shown that FGD5P1 is involved in the regulation of inflammation, and that it has anti-inflammatory effects.

FGD5P1 is also shown to be involved in the regulation of fibrosis, which is the process by which cells become cancerous. Studies have shown that FGD5P1 plays a role in the regulation of fibrosis and that it has anti-fibrosis effects.

FGD5P1 has also been shown to be involved in the regulation of cellular processes that are important for tissue repair and regeneration. For example, studies have shown that FGD5P1 is involved in the regulation of the angiogenesis, which is the process by which new blood vessels are formed in response to injury or damage.

In conclusion, FGD5P1 is a protein that is expressed in various tissues of the body and is involved in a wide range of cellular processes that are important for overall health and wellbeing. Its unique structural domain and its involvement in various cellular processes make it an attractive drug target or biomarker for future scientific research. Further studies are needed to fully understand the role of FGD5P1 in the regulation of cellular processes and its potential as a drug or biomarker.

Protein Name: FYVE, RhoGEF And PH Domain Containing 5 Pseudogene 1

The "FGD5P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FGD5P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets